Results 191 to 200 of about 40,816 (237)
Some of the next articles are maybe not open access.
Current Medicinal Chemistry, 2001
Resistance to glycopeptides in enterococci, which first emerged in the late 1980's and is now widespread mainly in the United States, is posing a serious clinical problem due to the lack of alternative and efficacious therapeutic options, particularly against infections caused by VanA strains that are highly resistant to glycopeptides and almost all ...
A, Malabarba, R, Ciabatti
openaire +2 more sources
Resistance to glycopeptides in enterococci, which first emerged in the late 1980's and is now widespread mainly in the United States, is posing a serious clinical problem due to the lack of alternative and efficacious therapeutic options, particularly against infections caused by VanA strains that are highly resistant to glycopeptides and almost all ...
A, Malabarba, R, Ciabatti
openaire +2 more sources
ChemInform, 2005
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Mickael Mogemark, Jan Kihlberg
openaire +1 more source
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Mickael Mogemark, Jan Kihlberg
openaire +1 more source
The Journal of Clinical Pharmacology, 1988
Numerous glycopeptides continue to be described in the literature. They all share a similar heptapeptidic structure with a fixed spatial configuration that forms the basis of their ability to recognize D-alanyl-D-alanine-containing structures in the cell wall.
openaire +2 more sources
Numerous glycopeptides continue to be described in the literature. They all share a similar heptapeptidic structure with a fixed spatial configuration that forms the basis of their ability to recognize D-alanyl-D-alanine-containing structures in the cell wall.
openaire +2 more sources
1998
Abstract Vancomycin is the only glycopeptide antibiotic licensed for clinical use in the United States. Another glycopeptide antibiotic, teicoplanin, is currently in clinical use in Europe, where, in addition, the glycopeptide avoparcin has been used in chicken and ruminant livestock feed as a growth promoter.
Adel S Sulaiman +2 more
openaire +1 more source
Abstract Vancomycin is the only glycopeptide antibiotic licensed for clinical use in the United States. Another glycopeptide antibiotic, teicoplanin, is currently in clinical use in Europe, where, in addition, the glycopeptide avoparcin has been used in chicken and ruminant livestock feed as a growth promoter.
Adel S Sulaiman +2 more
openaire +1 more source
Current Protocols in Molecular Biology, 1995
AbstractGeneration of glycopeptides from glycoproteins is frequently useful when analyzing a protein's oligosaccharide side chains. Freed from the bulk of the polypeptide backbone by proteolysis, glycopeptides can be characterized by a variety of techniques.
openaire +2 more sources
AbstractGeneration of glycopeptides from glycoproteins is frequently useful when analyzing a protein's oligosaccharide side chains. Freed from the bulk of the polypeptide backbone by proteolysis, glycopeptides can be characterized by a variety of techniques.
openaire +2 more sources
Glycopeptide Antibiotic Resistance
Annual Review of Pharmacology and Toxicology, 2002Glycopeptide antibiotics are integral components of the current antibiotic arsenal that is under strong pressures as a result of the emergence of a variety of resistance mechanisms over the past 15 years. Resistance has manifested itself largely through the expression of genes that encode proteins that reprogram cell wall biosynthesis and thus evade ...
Jeff, Pootoolal +2 more
openaire +2 more sources
Annales francaises d'anesthesie et de reanimation, 2000
To review pharmacology, pharmacokinetic and therapeutic use of glycopeptides in intensive care units.Extraction from Medline database of French and English articles on glycopeptides and search along with major review articles.The collected articles were reviewed and selected according to their quality and originality. The more recent data were selected.
M, Léone, M L, Ayem, C, Martin
openaire +1 more source
To review pharmacology, pharmacokinetic and therapeutic use of glycopeptides in intensive care units.Extraction from Medline database of French and English articles on glycopeptides and search along with major review articles.The collected articles were reviewed and selected according to their quality and originality. The more recent data were selected.
M, Léone, M L, Ayem, C, Martin
openaire +1 more source
2010
Oligosaccharides in protein play important roles in several biological events. In order to investigate the functions of oligosaccharides of protein, glycoproteins having homogeneous oligosaccharides should be prepared. For this purpose, preparation methods of diverse complex-type oligosaccharides as well as synthetic methods of glycopeptides are ...
Yasuhiro, Kajihara +3 more
openaire +2 more sources
Oligosaccharides in protein play important roles in several biological events. In order to investigate the functions of oligosaccharides of protein, glycoproteins having homogeneous oligosaccharides should be prepared. For this purpose, preparation methods of diverse complex-type oligosaccharides as well as synthetic methods of glycopeptides are ...
Yasuhiro, Kajihara +3 more
openaire +2 more sources
Glycopeptides and nephrotoxicity
Intensive Care Medicine, 1994Infections due to Gram-positive bacteria have become an increasing problem in the ICU. Furthermore, multidrug resistance among Gram-positive pathogens is increasingly recognized. Empirical therapy with antibiotic regimens that are effective against Gram-positive pathogens is often required in the ICU.
A W, Chow, R M, Azar
openaire +2 more sources
Mini-Reviews in Medicinal Chemistry, 2003
The presence of carbohydrate side-chains in native glycoproteins alters a number of biochemical properties of the peptide backbone. One of the most frequently studied questions is the conformation-modifying effect of sugar incorporation into asparagine, serine and threonine residues.
Laszlo, Otvos, Mare, Cudic
openaire +2 more sources
The presence of carbohydrate side-chains in native glycoproteins alters a number of biochemical properties of the peptide backbone. One of the most frequently studied questions is the conformation-modifying effect of sugar incorporation into asparagine, serine and threonine residues.
Laszlo, Otvos, Mare, Cudic
openaire +2 more sources